ArticleMethods in molecular biology (Clifton, N.J.)2026
Bioenergetic Profiling Applied to a Zebrafish Model of Neuronal Ceroid Lipofuscinosis, a Lysosomal Storage Disorder.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Mitochondrial regulation of brain development: evidence from zebrafish models.Fish physiology and biochemistry · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neuronal Ceroid Lipofuscinoses (NCLs) are a group of inherited neurodegenerative disorders characterized by autofluorescent lipopigment accumulation. NCLs consist of various types, spanning from CLN1 to CLN14 (except for "CLN9"), each linked to a particular mutated gene. Although the symptoms exhibit resemblances, the age at which each symptom manifests differs across the distinct types. Mitochondrial impairment has been implicated in the pathogenesis of NCLs, with studies suggesting contributions from dysfunctional oxidative phosphorylation and altered mitochondrial membrane potential to the progressive neurodegeneration observed in affected individuals. Utilizing Seahorse XF Analyzer, this study presents a method for the nuanced exploration of mitochondrial function and cellular metabolism, offering insights into potential therapeutic avenues. Zebrafish models reveal phenotypic similarities to human patients, making them promising for disease studies. Our research optimizes the Seahorse Mito Stress assay at 2 days post-fertilization (dpf) in zebrafish. This emerging approach holds great promise for identifying novel therapies.
Indexed as
Identifiers
41082122What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.